The Patent Finder

Impact Therapeutics, Inc.

Also on record
Records under this name other than the patents Impact Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Impact Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,825,246Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,133,900Use of Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,138,199Use of Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,528,143Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,090,568Quinazolinediones and their use
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,391,094Compositions and Methods for Treating Myelofibrosis
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,358,9551-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,179,392Solid pharmaceutical formulation of PARP inhibitors and use thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,562,889Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,703,7598,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones
Formerly held
In force
 · USPTO record
In forceUSPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited